Prof. Helen Coleman
Professor of Cancer Epidemiology, Centre for Public Health, Queen's University Belfast
Professor Helen Coleman is Lead of the Cancer Epidemiology Research Group at the Centre for Public Health at Queen’s University Belfast.
She has published over 90 peer-reviewed articles on the epidemiology of gastrointestinal cancers and pre-malignant conditions, with particular interests in Barrett’s oesophagus and oesophageal adenocarcinoma, colorectal polyps and colorectal cancer.
In addition to mainstay interests in the role of modifiable risk factors (such as smoking, alcohol and nutrition) in cancer risk and progression, she had specialist interests in clinical epidemiology related to gastrointestinal pathology diagnosis trends and concordance, and molecular pathology epidemiology.
Professor Coleman has over 10 years of experience working with the population-based Northern Ireland Barrett’s register, which is housed within the Northern Ireland Cancer Registry. She has also conducted many systematic reviews of lifestyle factors and biomarkers in cancer risk and progression.
Professor Coleman is affiliated to the Centre for Cancer Research and Cell Biology at Queen’s University Belfast, and is currently a Visiting Scientist with the Fitzgerald Lab at the MRC Cancer Unit, Cambridge, to further enhance interdisciplinary research efforts in oesophageal cancer as part of a Cancer Research UK funded Career Establishment Award (2018-2024).
Title: ‘Insights from Molecular Pathology Epidemiology studies of Oesophageal and Colorectal Neoplasia’
Summary: This talk will outline the application of molecular pathology epidemiology (MPE) studies to gastrointestinal neoplasia progression.
MPE studies investigate the interaction between biomarkers and epidemiological risk factors to better understand why some patients with pre-malignant conditions of the gastrointestinal tract develop cancer, and how these may interact to influence survival following a cancer diagnosis.
Professor Coleman will outline her current research from Cancer Research UK and other funded MPE studies of oesophageal and colorectal neoplasia progression.
This includes findings from a large inter-disciplinary cohort of 700 population-representative Stage II and III colon adenocarcinoma patients diagnosed between 2004-2008 in Northern Ireland, and new research within the UK OCCAMS consortium of over 3,000 oesophageal cancer patients.
We have a number of membership categories available. Find out which membership suits you.
Due to COVID restrictions we have yet to confirm the dates for 57th Annual Conference.
Please check back here later in 2020 to check for updates.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
The Irish Association for Cancer Research will support a limited number of Educational Grants that will be made available to postgraduate PhD researchers who have been affected by the Covid-19 pandemic. We acknowledge that many of our members have been significantly impacted by the recent pandemic that may have affected their ability to continue and/or complete research projects.
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven